Verily

Verily Life Sciences LLC, also known as Verily (formerly Google Life Sciences), is Alphabet Inc.'s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, until August 10, 2015, when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc. with restructuring completed on October 2, 2015. On December 7, 2015, Google Life Sciences was renamed Verily.
Early Researchers
At the time of Verily's formation in 2015, the members of the research team that contributed to the founding patent portfolio include:
History
On 9 September 2014, the division acquired Lift Labs, the makers of Liftware.
Verily Life Sciences in January 2019 raised $1 billion in funding.
At the end of 2019, Verily sold its stake in robot-assisted surgery joint venture Verb Surgical to development partner Johnson & Johnson.
In August 2020, Verily announced that it is entering into the insurance market with the launch of Coefficient Insurance Company. The new subsidiary will be backed by Swiss Re Group's commercial insurance unit.
In September 2022, Verily announced longtime CEO Andy Conrad would step down as CEO in January 2023, to be replaced by Stephen Gillett who became CEO on January 3, 2023.
In January 2023, fifteen percent of Verily's workforce was laid off as part of a broader restructuring by parent company, Alphabet. The Information reported in August that Gillett had told employees they would stop relying on Alphabet on "a wide range of corporate services", signaling a potential spin-out as an independent company.
Projects
The Dexcom G7 continuous glucose monitors (CGM), developed in partnership with Dexcom, was FDA approved and launched worldwide in 2022.
Galvani Bioelectronics, treating chronic conditions, including Rheumatoid Arthritis (RA), through targeted neuromodulation therapies, a joint venture with GlaxoSmithKline
Verb Surgical, for advancements in surgical robotics, a joint venture with Johnson & Johnson.
A spoon for people with tremors as part of Lift Labs acquisition.
The Baseline Study, a project to collect genetic, molecular, and wearable device information from enough people to create a picture of what a healthy human should be.
Onduo, a chronic disease management platform for patient with Diabetes, developed in partnership with Sanofi.
Study Watch, a health-tracking watch for clinical trials.
Discontinued
Contact lenses that allow people with diabetes to continually check their glucose levels using a non-intrusive method. On November 16, 2018, Verily announced it discontinued this project.
Smart shoes for health tracking and fall detection
Skin research with L’Oréal
A disease-detecting nanoparticle platform working with the wristband, a project called Tricorder.
See also
Calico
Galvani Bioelectronics
References
Alphabet Inc.
Alphabet Inc. subsidiaries
American medical research
Biotechnology companies of the United States
Life sciences industry
Science and technology in the San Francisco Bay Area
Transhumanist organizations
Companies based in South San Francisco, California
Biotechnology companies established in 2015
2015 establishments in California